a public good project by the
Synthesis
Company
of California

© 2026

Sylvie Mazoyer | doi.page

0 works0 citations0 h-index

Sylvie Mazoyer

Université Claude Bernard Lyon 1(FR)Centre National de la Recherche Scientifique(FR)Radboud University Nijmegen(NL)Inserm(FR)Radboud University Medical Center(NL)Centre de Recherche en Cancérologie de Lyon(FR)

Publications by Year

Research Areas

BRCA gene mutations in cancer, CRISPR and Genetic Engineering, Genomic variations and chromosomal abnormalities, Nutrition, Genetics, and Disease, DNA Repair Mechanisms

Most-Cited Works

→ Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation(1995)500 cited
→ Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer(2015)494 cited
→ A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population(2010)341 cited
Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.(1996)
→ Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers(2008)284 cited
→ Down‐regulation of BRCA1 expression by miR‐146a and miR‐146b‐5p in triple negative sporadic breast cancers(2011)261 cited

→ Identification of six new susceptibility loci for invasive epithelial ovarian cancer(2015)

259 cited

Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions.(1999)

→ Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants(2012)239 cited

→ Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores(2017)181 cited